Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Change in Accured Expenses (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed Change in Accured Expenses for 3 consecutive years, with -$4548.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Accured Expenses rose 99.95% year-over-year to -$4548.0, compared with a TTM value of $9.0 million through Sep 2025, up 293.15%, and an annual FY2024 reading of $40215.0, down 99.1% over the prior year.
  • Change in Accured Expenses was -$4548.0 for Q3 2025 at SBC Medical Group Holdings, down from $9412.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $9.1 million in Q4 2024 and bottomed at -$9.1 million in Q3 2024.
  • Average Change in Accured Expenses over 3 years is $399917.8, with a median of $9412.0 recorded in 2025.
  • Peak annual rise in Change in Accured Expenses hit 106.97% in 2024, while the deepest fall reached 4472.16% in 2024.
  • Year by year, Change in Accured Expenses stood at $4.4 million in 2023, then skyrocketed by 106.97% to $9.1 million in 2024, then plummeted by 100.05% to -$4548.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for SBC at -$4548.0 in Q3 2025, $9412.0 in Q2 2025, and -$98005.0 in Q1 2025.